Thanks again. A couple other thoughts on his niche market due to no NIH funding for the device. With little or no competition for the device probably enables him to charge a premium. And as he notes it’s not a cure so he inherently has a continually evaporating customer base. So I’d guess he requires a upfront payment or a sizable chunk thereof and/or guaranteed payments. Because once that customer base expires it becomes inherently harder to collect for services. Make of what you will. But people in a unfortunate situation with GBM and means are going weigh their options. Not an easy predicament by any measure for anyone.